QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 euda-health-signs-loi-to-acquire-go-posb-plans-ipsc-lab-in-china-to-expand-regenerative-medicine-and-therapeutic-solutions-no-financial-terms-disclosed

EUDA Health Holdings Limited (NASDAQ:EUDA) ("EUDA" or the "Company"), a Singapore-based non-invasive healthcare...

 euda-health-signs-loi-to-acquire-singapore-biotech-firm-chemokine-expanding-into-gene-modulating-supplements-terms-not-disclosed

EUDA Health Holdings Limited (NASDAQ:EUDA) ("EUDA" or the "Company"), a leading Singapore-based non-invasive he...

 euda-health-holdings-unit-secures-exclusive-worldwide-distribution-rights-for-an-immune-health-supplement-from-chemokine

-SEC Filing

 euda-health-secures-global-rights-to-gene-modulating-immune-supplement-launches-euda-helix-in-asia

EUDA Health Holdings Limited (NASDAQ:EUDA) ("EUDA" or the "Company"), a leading Singapore-based non-invasive he...

 euda-enters-partnership-with-authorized-distributor-of-guangdong-cell-biotech-to-offer-stem-cell-therapies-to-customers-in-singapore-and-malaysia

EUDA Health Holdings Limited ("EUDA" or the "Company") (NASDAQ: EUDA), a Singapore-based property management se...

 euda-health-holdings-says-on-feb-6-chen-wei-wen-kelvin-tendered-resignation-from-his-position-as-ceo-and-executive-director-co-appoints-alfred-lim-as-cos-ceo

- SEC Filing

 euda-enters-preliminary-discussions-with-guangdong-cell-biotech-to-form-joint-venture

This potential collaboration aims to leverage the complementary strengths of both companies to accelerate growth and innovation...

 euda-health-holdings-files-for-100m-mixed-shelf

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION